Eisai
4523.T
#2300
Rank
C$11.68 B
Marketcap
C$41.39
Share price
-0.60%
Change (1 day)
-2.26%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.24. In 2026 the company made an earnings per share (EPS) of C$1.23 a decrease over its 2025 EPS that were of C$1.56.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026C$1.23-21.04%
2025C$1.5611.85%
2024C$1.39-32.63%
2023C$2.075.52%
2022C$1.96-74.01%
2021C$7.54-66.58%
2020C$22.5698.24%
2019C$11.3817.01%
2018C$9.7337.78%
2017C$7.06-27.62%
2016C$9.7535.33%
2015C$7.21-2.82%
2014C$7.42-27.66%
2013C$10.25-27.49%
2012C$14.14-12.67%
2011C$16.1988.08%
2010C$8.61-11.06%
2009C$9.68-390.15%
2008C-$3.34-127.78%
2007C$12.01347.11%
2006C$2.694.38%
2005C$2.577.4%
2004C$2.4043.03%
2003C$1.6825.09%
2002C$1.3452.67%
2001C$0.8869.76%
2000C$0.52